Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022)

Cartesian Therapeutics (RNAC) has disclosed Current Taxes for 2 consecutive years, with $320000.0 as the latest value for Q2 2022.

  • On a quarterly basis, Current Taxes changed N/A to $320000.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $320000.0, a N/A change, with the full-year FY2021 number at $601000.0, changed N/A from a year prior.
  • Current Taxes was $320000.0 for Q2 2022 at Cartesian Therapeutics, roughly flat from $320000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $15.8 million in Q3 2021 to a low of $320000.0 in Q1 2022.